iTeos Therapeutics, Inc.
ITOS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $208 | $157 | $142 | $124 |
| Short-Term Investments | $308 | $364 | $353 | $365 |
| Receivables | $3 | $3 | $4 | $43 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $13 | $11 | $13 |
| Total Curr. Assets | $529 | $537 | $510 | $545 |
| Property Plant & Equip (Net) | $10 | $10 | $10 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $75 | $104 | $160 | $160 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $8 | $7 | $7 |
| Total NC Assets | $94 | $122 | $177 | $178 |
| Other Assets | -$0 | $0 | $0 | $0 |
| Total Assets | $623 | $659 | $687 | $723 |
| Liabilities | – | – | – | – |
| Payables | $6 | $14 | $9 | $7 |
| Short-Term Debt | $2 | $1 | $1 | $1 |
| Tax Payable | $0 | $2 | $0 | $6 |
| Deferred Revenue | $1 | $2 | $1 | $1 |
| Other Curr. Liab. | $61 | $19 | $29 | $21 |
| Total Curr. Liab. | $70 | $38 | $40 | $37 |
| LT Debt | $4 | $4 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $55 | $54 | $53 | $50 |
| Total NC Liab. | $59 | $57 | $56 | $55 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $6 |
| Total Liabilities | $129 | $95 | $97 | $91 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$123 | -$44 | -$10 | $34 |
| AOCI | -$16 | -$15 | -$16 | -$11 |
| Other Equity | $633 | $623 | $616 | $609 |
| Total Equity | $494 | $563 | $590 | $632 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $623 | $659 | $687 | $723 |
| Net Debt | -$203 | -$151 | -$137 | -$118 |